# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040323
Filing Date
2023-11-13
Accepted
2023-11-13 08:01:04
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1173652
2 |  | ex31-1.htm | EX-31.1 | 11357
3 |  | ex31-2.htm | EX-31.2 | 11359
4 |  | ex-32.htm | EX-32 | 6899
| Complete submission text file | 0001493152-23-040323.txt |  | 6099732

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | abeo-20230930.xsd | EX-101.SCH | 39580
6 | XBRL CALCULATION FILE | abeo-20230930_cal.xml | EX-101.CAL | 65052
7 | XBRL DEFINITION FILE | abeo-20230930_def.xml | EX-101.DEF | 191204
8 | XBRL LABEL FILE | abeo-20230930_lab.xml | EX-101.LAB | 369200
9 | XBRL PRESENTATION FILE | abeo-20230930_pre.xml | EX-101.PRE | 294509
61 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1020064

Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 231395238
SIC: 2834 Pharmaceutical Preparations